lucidenic acid N

Metabolite details

Identifier

YBGBNHHXOJXFNM-UQCMLMITSA-N

InChI Key

YBGBNHHXOJXFNM-UQCMLMITSA-N

IUPAC name

(3β,5α,7β)-3,7-dihydroxy-4,4,14-trimethyl-11,15-dioxochol-8-en-24-oic acid

Preferred name

lucidenic acid N

INN name

—

Synonym

3,7-Dihydroxy-25,26,27-trinor-11,15-dioxolanost-8-en-24-oic acid

ChEBI

CHEBI:66595

Reactome pathways

• No Reactome pathways listed for this metabolite.

Observed in studies

• Metabolic Dynamics of In Vitro CD8+ T Cell Activation.
• High complexity and diel dynamics of planktonic microbiome revealed by multi-omics in Taihu, China
• Mechanism of interventional effect and targets of Zhuyu Pill in regulating and suppressing colitis and cholestasis
• Alterations in the gut microbiota and metabolomics of seafarers after a six-month sea voyage

Observed in differential profiles

• G3_Experimental_Sample_0h_vs_G11_Experimental_Sample_96h
• 2:00 AM_Membrane_vs_2:00 AM_Net
• Control_vs_ZYP_High_Dose
• Control_0d_vs_Treatment_180d